Trupanion (NASDAQ:TRUP) Issues Quarterly Earnings Results

Trupanion (NASDAQ:TRUP) announced its quarterly earnings results on Thursday. The financial services provider reported $0.13 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.76), FiscalAI reports. Trupanion had a return on equity of 3.31% and a net margin of 0.81%.The company had revenue of $366.92 million during the quarter, compared to analysts’ expectations of $361.58 million. During the same quarter in the previous year, the firm earned $0.03 EPS. The firm’s revenue for the quarter was up 12.0% compared to the same quarter last year. Trupanion updated its Q4 2025 guidance to EPS and its FY 2025 guidance to EPS.

Trupanion Trading Down 0.9%

Shares of NASDAQ TRUP opened at $42.09 on Friday. Trupanion has a fifty-two week low of $31.00 and a fifty-two week high of $57.88. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.69 and a current ratio of 1.69. The company has a market cap of $1.81 billion, a price-to-earnings ratio of 161.89 and a beta of 1.82. The business’s 50 day moving average price is $43.18 and its 200-day moving average price is $46.31.

Insider Buying and Selling at Trupanion

In other Trupanion news, CFO Fawwad Qureshi sold 2,800 shares of the stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $45.56, for a total value of $127,568.00. Following the sale, the chief financial officer owned 6,451 shares in the company, valued at $293,907.56. This trade represents a 30.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Margaret Tooth sold 8,961 shares of the business’s stock in a transaction on Thursday, September 25th. The shares were sold at an average price of $41.88, for a total transaction of $375,286.68. Following the sale, the chief executive officer directly owned 144,229 shares of the company’s stock, valued at $6,040,310.52. This represents a 5.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 70,645 shares of company stock valued at $3,128,119 in the last quarter. 5.42% of the stock is owned by insiders.

Hedge Funds Weigh In On Trupanion

A number of institutional investors have recently modified their holdings of the stock. Thrivent Financial for Lutherans boosted its holdings in shares of Trupanion by 1.1% in the second quarter. Thrivent Financial for Lutherans now owns 24,853 shares of the financial services provider’s stock valued at $1,376,000 after purchasing an additional 282 shares during the period. EP Wealth Advisors LLC raised its position in Trupanion by 2.9% during the 2nd quarter. EP Wealth Advisors LLC now owns 10,310 shares of the financial services provider’s stock valued at $571,000 after purchasing an additional 292 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Trupanion by 3.8% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,340 shares of the financial services provider’s stock worth $1,126,000 after buying an additional 737 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in shares of Trupanion by 6.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 18,622 shares of the financial services provider’s stock worth $1,031,000 after buying an additional 1,177 shares during the period. Finally, Sei Investments Co. grew its position in shares of Trupanion by 27.8% during the 2nd quarter. Sei Investments Co. now owns 8,711 shares of the financial services provider’s stock worth $482,000 after buying an additional 1,893 shares in the last quarter.

Analysts Set New Price Targets

TRUP has been the subject of several research reports. Stifel Nicolaus increased their price objective on shares of Trupanion from $41.00 to $45.00 and gave the company a “hold” rating in a research report on Friday, August 8th. Cantor Fitzgerald raised shares of Trupanion to a “hold” rating in a report on Wednesday, August 13th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Trupanion in a research report on Wednesday, October 8th. Finally, Piper Sandler upped their price objective on Trupanion from $62.00 to $67.00 and gave the company an “overweight” rating in a research report on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, Trupanion currently has a consensus rating of “Hold” and an average target price of $54.75.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.